v3.25.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at beginning at Dec. 31, 2023 $ 76 $ 901,471 $ 92 $ (676,421) $ 225,218
Balance at beginning (in shares) at Dec. 31, 2023 75,979,495        
Increase (decrease) in Stockholders' Equity          
Unrealized gain (loss) on marketable securities     68   68
Sale of common shares and pre-funded warrants to purchase common shares, net $ 12 324,402     324,414
Sale of common shares and pre-funded warrants to purchase common shares, net (in Shares) 11,858,408        
Exercise of stock options $ 1 18,974     18,975
Exercise of stock options (in shares) 1,469,756        
Issuance of common shares upon RSU vesting $ 1 (1)      
Issuance of common shares upon RSU vesting (in shares) 679,694        
Exercise of pre-funded and common warrants $ 4 9,621     9,625
Exercise of pre-funded and common warrants (in shares) 3,836,325        
Equity-based compensation expense   36,628     36,628
Net Income (Loss)       (246,294) (246,294)
Balance at end at Dec. 31, 2024 $ 94 1,291,095 160 (922,715) 368,634
Balance at end (in shares) at Dec. 31, 2024 93,823,678        
Increase (decrease) in Stockholders' Equity          
Unrealized gain (loss) on marketable securities     (64)   (64)
Sale of common shares and pre-funded warrants to purchase common shares, net $ 3 91,657     91,660
Sale of common shares and pre-funded warrants to purchase common shares, net (in Shares) 2,767,000        
Exercise of stock options $ 1 23,810     23,811
Exercise of stock options (in shares) 1,860,105        
Issuance of common shares upon RSU vesting $ 1 (1)      
Issuance of common shares upon RSU vesting (in shares) 1,331,907        
Exercise of pre-funded and common warrants $ 9 63,779     63,788
Exercise of pre-funded and common warrants (in shares) 8,678,664        
Equity-based compensation expense   75,600     75,600
Foreign currency translation adjustments     (2)   (2)
Net Income (Loss)       (377,939) (377,939)
Balance at end at Dec. 31, 2025 $ 108 $ 1,545,940 $ 94 $ (1,300,654) $ 245,488
Balance at end (in shares) at Dec. 31, 2025 108,461,354